Hodgkin - CS I/II – untreated - 15-70 yrs – supradiaphragmatic - no NLPHL
*PET-/+ according to protocol criteria
2 ABVD
2 ABVD
2 BEACOPPesc+INRT 30 (+6)
H10F
P
E
T
2 ABVD
1 ABVD+INRT 30 Gy (+6)
PET
-
+
2 ABVD
4 ABVD
2 BEACOPPesc+INRT 30 (+6)
P
E
T
2 ABVD
2 ABVD+INRT 30 Gy (+6)
PET
-
+
R
H10U
R
*
*
EORTC/GELA/IIL H10 Study
Results of PET+ patients
H10 (#20051): study design